• Cisplatin in Cancer Stem Cell Targeting: New Insights for Re

  2026-05-22

  Explore how Cisplatin (CDDP) advances cancer research by targeting cancer stem cells and overcoming chemotherapy resistance. This article integrates emerging findings and practical protocols for apoptosis assays and tumor xenograft models.

• Pharmacokinetic Variability of CSBTA in MASH: Mechanistic In

  2026-05-22

  This study systematically characterizes how metabolic dysfunction-associated steatohepatitis (MASH) alters the pharmacokinetics and tissue distribution of Corydalis saxicola Bunting total alkaloids (CSBTA) in mice. Findings reveal disease-driven modulation of cytochrome P450 enzymes and transporters, guiding rational dose optimization for MASLD/MASH therapies.

• Fingolimod (FTY720): Next-Gen Immunomodulation for In Vivo T

  2026-05-21

  Explore how Fingolimod (FTY720) is transforming translational immunology. This article blends mechanistic insight and strategic guidance, spotlighting its use as an immunomodulatory agent in next-generation in vivo CAR-T-mimicking cell therapies. Drawing on recent breakthroughs in magnetic nano-antibody–guided T cell engineering, we provide translational researchers with actionable protocol parameters, competitive landscape analysis, and a forward-looking vision for immune cell engineering beyond multiple sclerosis.

• Entecavir (BMS200475): Protocols for HBV Replication Inhibit

  2026-05-21

  Entecavir stands out as a potent, selective HBV DNA polymerase inhibitor with proven efficacy in both wild-type and lamivudine-resistant strains. This article delivers advanced workflows and troubleshooting insights for maximizing reproducibility and translational value in chronic hepatitis B virus research using APExBIO's Entecavir.

• BIRB 796 (Doramapimod): Structural Mechanisms and Assay Impa

  2026-05-20

  Discover how BIRB 796 (Doramapimod) shapes inflammation and apoptosis research through allosteric p38α MAPK inhibition, revealing new structural insights and practical assay guidance. This article offers a distinct, in-depth look at conformational control and experimental design considerations.

• ATG4B Nuclear Translocation Links Energy Deficiency to DNA R

  2026-05-20

  This study reveals a novel mechanism where cellular energy deficiency triggers ATG4B nuclear translocation, inhibiting PRMT1-mediated DNA repair and promoting acute myeloid leukemia (AML) progression. The findings provide molecular insight into how metabolic stress drives genomic instability in cancer and suggest ATG4B as a therapeutic target for restoring DNA repair capacity.

• Tioconazole in Antifungal Research: Integrating Mechanism, M

  2026-05-19

  Discover how Tioconazole, a potent antifungal medication, advances research through its unique mechanism and integration of metabolic-genomic insights. This article offers an in-depth perspective on Tioconazole’s role in antifungal drug development, practical assay design, and the impact of cellular energy metabolism.

• PD 173074: Precision FGFR1/VEGFR2 Inhibition in Disease Mode

  2026-05-19

  PD 173074 offers unmatched selectivity and nanomolar efficacy for dissecting FGFR and VEGFR signaling, empowering researchers to model angiogenesis inhibition and podocyte biology with reproducibility. This guide breaks down actionable workflows, nuanced troubleshooting, and translational insights from cutting-edge diabetic kidney disease studies.

• Gut-Brain Cholinergic Pathways in B. fragilis Seizure Suppre

  2026-05-18

  Jia et al. reveal that Bacteroides fragilis mediates antiseizure effects through a gut-brain cholinergic pathway involving enhanced vagal signaling and increased intestinal Lactobacillus colonization. Their mechanistic findings provide a translational framework for microbiota-targeted therapies in pediatric refractory epilepsy.

• Cy3 NHS Ester (Non-Sulfonated): Technical Guide and Best Pra

  2026-05-18

  Cy3 NHS ester (non-sulfonated) enables efficient, high-sensitivity fluorescent labeling of proteins, peptides, and oligonucleotides by targeting primary amines. It is ideal for workflows requiring orange fluorescence and compatibility with standard TRITC filter sets, but is not recommended where water-only labeling is essential or protein stability is highly sensitive to organic solvents.

• Serum-Free 6C Medium Prolongs Corneal Epithelial Cell Prolif

  2026-05-17

  An et al. developed a novel, serum-free 6C culture medium that significantly extends the proliferative capacity of mouse corneal epithelial cells (mCECs) in vitro and in vivo. By combining six small-molecule pathway modulators—including DAPT (GSI-IX)—the study demonstrates improved maintenance of progenitor cell characteristics, offering a robust platform for regenerative ophthalmology research.

• MLN4924: Mechanistic Insights and Translational Impact in Ne

  2026-05-16

  Explore the mechanistic underpinnings of MLN4924, a potent NEDD8-activating enzyme inhibitor, and its transformative role in cancer biology research. This article uniquely integrates structural, functional, and translational insights, offering advanced guidance for researchers targeting the neddylation pathway.

• Oleanolic Acid: Mechanisms and Protocols for Antiviral Resea

  2026-05-15

  Oleanolic acid is a natural triterpenoid with validated inducible nitric oxide synthase (iNOS) induction and cyclooxygenase-2 (COX-2) modulation properties. It is widely used as an antiviral research compound, especially in dual-loaded liposome systems, where accurate encapsulation efficiency and workflow integration are critical. This article delivers verifiable, structured evidence for the compound’s utility and limitations in immune response and inflammation pathway research.

• 8-Chloroadenosine: Strategic Disruption of RNA in NSCLC Rese

  2026-05-15

  This article explores the mechanistic and translational value of 8-Chloroadenosine, a nucleoside analog and potent RNA synthesis inhibitor, in advancing transcriptional regulation research and cancer therapeutics. Building on recent insights into lncRNA-mediated IL-6 stabilization in non-small cell lung cancer (NSCLC), we examine how high-purity 8-Chloroadenosine from APExBIO enables precision probing of RNA metabolism and transcriptional control. We offer strategic guidance for experimental design, highlight protocol parameters, and position this reagent within the evolving landscape of molecular and translational oncology.

• Distinct Shh, Fgf10, and Fgfr2 Patterns Shape Penile Develop

  2026-05-14

  This study reveals that differences in the timing and expression of Shh, Fgf10, and Fgfr2 control the formation of the prepuce and urethral groove in guinea pigs versus mice. These insights refine comparative models of mammalian penile development, with implications for understanding normal and disordered urogenital morphogenesis.

448 records 17/30 page Previous Next First page 上5页 1617181920 下5页 Last page